(HLNE) Hamilton Lane - Overview
Sector: Financial Services | Industry: Asset Management | Exchange: NASDAQ (USA) | Market Cap: 4.839m USD | Total Return: -43.6% in 12m
Avg Turnover: 71.7M
EPS Trend: 95.4%
Qual. Beats: 4
Rev. Trend: 91.9%
Qual. Beats: 0
Warnings
Share dilution 32.7% YoY
Below Avwap Earnings
Tailwinds
Confidence
Hamilton Lane Incorporated (HLNE) is a global investment firm specializing in private markets across various stages, including venture capital, buyouts, and distressed debt. The firm manages diverse alternative investment strategies such as direct credit, funds-of-funds, and real assets, focusing on sectors ranging from disruptive technology to healthcare and industrials. Unlike traditional asset managers, Hamilton Lane operates in the private equity sector, which typically relies on long-term capital commitments and management fees based on committed or invested assets.
The firm targets small- to mid-sized enterprises globally, often seeking majority stakes with investment sizes ranging from $0.25 million to $100 million. Its business model benefits from the increasing institutional allocation to private markets, a sector that historically offers lower liquidity but higher potential returns compared to public equities. For a deeper look at its valuation metrics and peer comparisons, you may want to explore the data available on ValueRay.
Headquartered in Philadelphia and founded in 1991, Hamilton Lane maintains an extensive international footprint with offices across North America, Europe, Asia-Pacific, and the Middle East. This geographic diversity allows the firm to source deals in emerging markets like Southeast Asia and Latin America while maintaining a strong presence in established financial hubs.
- Management fee growth driven by increased assets under management in private markets
- Performance fee volatility tied to successful exits and investment realizations
- Expansion into retail and evergreen fund structures diversifies revenue base
- Global interest rate environment impacts private equity valuations and deal flow
- Rising operational expenses from international expansion and technology platform investments
| Net Income: 249.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 1.21 > 1.0 |
| NWC/Revenue: 28.34% < 20% (prev 27.96%; Δ 0.38% < -1%) |
| CFO/TA 0.20 > 3% & CFO 453.6m > Net Income 249.2m |
| Net Debt (70.6m) to EBITDA (487.8m): 0.14 < 3 |
| Current Ratio: 1.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (54.4m) vs 12m ago 32.70% < -2% |
| Gross Margin: 69.88% > 18% (prev 70.79%; Δ -0.92% > 0.5%) |
| Asset Turnover: 37.99% > 50% (prev 42.18%; Δ -4.18% > 0%) |
| Interest Coverage Ratio: 31.96 > 6 (EBIT TTM 477.9m / Interest Expense TTM 15.0m) |
| A: 0.09 (Total Current Assets 561.3m - Total Current Liabilities 346.2m) / Total Assets 2.30b |
| B: 0.27 (Retained Earnings 614.7m / Total Assets 2.30b) |
| C: 0.24 (EBIT TTM 477.9m / Avg Total Assets 2.00b) |
| D: 1.09 (Book Value of Equity 915.2m / Total Liabilities 838.4m) |
| Altman-Z'' = 4.24 = AA |
| DSRI: 0.83 (Receivables 175.7m/197.6m, Revenue 759.0m/713.0m) |
| GMI: 1.01 (GM 70.79% / 69.88%) |
| AQI: 1.10 (AQ_t 0.71 / AQ_t-1 0.65) |
| SGI: 1.06 (Revenue 759.0m / 713.0m) |
| TATA: -0.09 (NI 249.2m - CFO 453.6m) / TA 2.30b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of June 05, 2026, the stock is trading at USD 82.67 with a total of 1,163,837 shares traded.
Over the past week, the price has changed by -4.04%,
over one month by -9.27%,
over three months by -22.61% and
over the past year by -43.60%.
Hamilton Lane has received a consensus analysts rating of 2.83. Therefore, it is recommended to hold HLNE.
- StrongBuy: 0
- Buy: 0
- Hold: 5
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 136 | 64.5% |
P/E Trailing = 14.7179
P/E Forward = 13.8122
P/S = 6.0546
P/B = 4.318
P/EG = 1.39
Revenue TTM = 759.0m USD
EBIT TTM = 477.9m USD
EBITDA TTM = 487.8m USD
Long Term Debt = 278.4m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 434.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 78.1m
Net Debt = 70.6m USD (calculated: Debt 434.5m - CCE 363.9m)
Enterprise Value = 4.91b USD (4.84b + Debt 434.5m - CCE 363.9m)
Interest Coverage Ratio = 31.96 (Ebit TTM 477.9m / Interest Expense TTM 15.0m)
EV/FCF = 11.64x (Enterprise Value 4.91b / FCF TTM 421.6m)
FCF Yield = 8.59% (FCF TTM 421.6m / Enterprise Value 4.91b)
FCF Margin = 55.55% (FCF TTM 421.6m / Revenue TTM 759.0m)
Net Margin = 32.83% (Net Income TTM 249.2m / Revenue TTM 759.0m)
Gross Margin = 69.88% ((Revenue TTM 759.0m - Cost of Revenue TTM 228.6m) / Revenue TTM)
Gross Margin QoQ = 69.78% (prev 69.34%)
Tobins Q-Ratio = 2.13 (Enterprise Value 4.91b / Total Assets 2.30b)
Interest Expense / Debt = 3.44% (Interest Expense 15.0m / Debt 434.5m)
Taxrate = 16.25% (75.2m / 462.9m)
NOPAT = 400.2m (EBIT 477.9m * (1 - 16.25%))
Current Ratio = 1.62 (Total Current Assets 561.3m / Total Current Liabilities 346.2m)
Debt / Equity = 0.47 (Debt 434.5m / totalStockholderEquity, last quarter 915.2m)
Debt / EBITDA = 0.14 (Net Debt 70.6m / EBITDA 487.8m)
Debt / FCF = 0.17 (Net Debt 70.6m / FCF TTM 421.6m)
Total Stockholder Equity = 844.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.47% (Net Income 249.2m / Total Assets 2.30b)
RoE = 29.51% (Net Income TTM 249.2m / Total Stockholder Equity 844.3m)
RoCE = 42.56% (EBIT 477.9m / Capital Employed (Equity 844.3m + L.T.Debt 278.4m))
RoIC = 20.84% (NOPAT 400.2m / Invested Capital 1.92b)
WACC = 10.11% (E(4.84b)/V(5.27b) * Re(10.76%) + D(434.5m)/V(5.27b) * Rd(3.44%) * (1-Tc(0.16)))
Discount Rate = 10.76% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 43.19 | Cagr: 0.35%
[DCF] Terminal Value 72.49% ; FCFF base≈368.4m ; Y1≈422.3m ; Y5≈621.6m
[DCF] Fair Price = 161.7 (EV 7.13b - Net Debt 70.6m = Equity 7.06b / Shares 43.7m; r=10.11% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.41 | EPS CAGR: 24.70% | SUE: 0.85 | # QB: 4
Revenue Correlation: 91.87 | Revenue CAGR: 13.36% | SUE: -0.47 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.45 | Chg30d=+5.51% | Revisions=+25% | Analysts=6
EPS next Quarter (2026-09-30): EPS=1.50 | Chg30d=-0.76% | Revisions=+25% | Analysts=6
EPS current Year (2027-03-31): EPS=6.10 | Chg30d=+1.59% | Revisions=+20% | GrowthEPS=+3.4% | GrowthRev=+16.8%
EPS next Year (2028-03-31): EPS=7.40 | Chg30d=-0.55% | Revisions=-25% | GrowthEPS=+21.3% | GrowthRev=+18.6%
[Analyst] Revisions Ratio: +25%